2015

Montse Ballarín ”Innovation should be integrated in the culture of research institutions”

On November 24 the conference hall of the University Hospital of Bellvitge (HUB) hosted the presentation of the book ¿Innovas o trabajas? De la idea al paciente written by members of the IDIBELL Unity of Innovation Montse Ballarin, Jaime Ruiz, Eva Olivera and Jose Maria Sanchez, supported by ACC10. Those in charge of opening the […]

Montse Ballarín ”Innovation should be integrated in the culture of research institutions” Read More »

Evolution of severely immunosuppressed HIV patients depends on the immunologic and virologic response to treatment, regardless of the initial state

So far only it takes into account the baseline of the patients The study concludes that in spite that even in the worst scenario the patient may control the virus, treatment should begin from the time of diagnosis More than half of patients arrive late to treatment Article reference

Evolution of severely immunosuppressed HIV patients depends on the immunologic and virologic response to treatment, regardless of the initial state Read More »

UB, IDIBELL and the company FCTecnics collaborate on a project to develop a technology that allows advance the research of neurodegenerative d

The invention is an extensometer designed for researchers to conduct experiments of mechanical stress with large biological structures, such as nerves, tendons, muscles, in the search for neurodegenerative diseases such as Charcot-Marie -tooth. The project by the research group of Dr. Carlos Solsona, professor of the Department of Pathology and Experimental Therapeutics at the University

UB, IDIBELL and the company FCTecnics collaborate on a project to develop a technology that allows advance the research of neurodegenerative d Read More »

La Marató de TV3 funds five projects of IDIBELL and CMRB

La Marató de TV3 Foundation, which just a year ago was dedicated to raise funds for research into heart disease, will finance three research projects of the Bellvitge Biomedical Research Institute (IDIBELL), and two of the Center for Regenerative Medicine of Catalonia (CMRB). The ceremony took place on November 5, at the Academy of Medical

La Marató de TV3 funds five projects of IDIBELL and CMRB Read More »

Precipita platform raises funds for research in Cornelia de Lange syndrome at IDIBELL

The Cornelia de Lange Syndrome (CDLS) is a very rare disease characterized by severe mental and growth retardation, and a characteristic facial dimorphism. In severe cases, there is total or partial absence of the upper limbs and psychomotor deficits have so often come to not walk. Researchers of the Cell cycle research group at the

Precipita platform raises funds for research in Cornelia de Lange syndrome at IDIBELL Read More »

Researchers identify molecules with potential therapeutic use as immunosuppressive agents

Researchers from the Human Molecular Genetics at IDIBELL, led by Mercè Pérez, of the Autonomous University of Barcelona and the CIMA Clinic of Navarra, has identified two small organic compounds that compete with NFATc to join in the same place calcineurin protein and that could have a potential immunosuppressive effect. Activation of the immune response

Researchers identify molecules with potential therapeutic use as immunosuppressive agents Read More »

Scroll to Top